BIOMAT Database Logo BIOMAT Database Logo

[Treatment with zidovudine of thrombopenia associated with human immunodeficiency virus infection. Changes in erythropoiesis]. 1989

E Aguilar Ligorit, and I Benet Monforte, and A Pascual López, and J García-Conde Bru

UI MeSH Term Description Entries
D004920 Erythropoiesis The production of red blood cells (ERYTHROCYTES). In humans, erythrocytes are produced by the YOLK SAC in the first trimester; by the liver in the second trimester; by the BONE MARROW in the third trimester and after birth. In normal individuals, the erythrocyte count in the peripheral blood remains relatively constant implying a balance between the rate of erythrocyte production and rate of destruction. Erythropoieses
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000163 Acquired Immunodeficiency Syndrome An acquired defect of cellular immunity associated with infection by the human immunodeficiency virus (HIV), a CD4-positive T-lymphocyte count under 200 cells/microliter or less than 14% of total lymphocytes, and increased susceptibility to opportunistic infections and malignant neoplasms. Clinical manifestations also include emaciation (wasting) and dementia. These elements reflect criteria for AIDS as defined by the CDC in 1993. AIDS,Immunodeficiency Syndrome, Acquired,Immunologic Deficiency Syndrome, Acquired,Acquired Immune Deficiency Syndrome,Acquired Immuno-Deficiency Syndrome,Acquired Immuno Deficiency Syndrome,Acquired Immuno-Deficiency Syndromes,Acquired Immunodeficiency Syndromes,Immuno-Deficiency Syndrome, Acquired,Immuno-Deficiency Syndromes, Acquired,Immunodeficiency Syndromes, Acquired,Syndrome, Acquired Immuno-Deficiency,Syndrome, Acquired Immunodeficiency,Syndromes, Acquired Immuno-Deficiency,Syndromes, Acquired Immunodeficiency
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D013921 Thrombocytopenia A subnormal level of BLOOD PLATELETS. Thrombopenia,Thrombocytopenias,Thrombopenias
D015215 Zidovudine A dideoxynucleoside compound in which the 3'-hydroxy group on the sugar moiety has been replaced by an azido group. This modification prevents the formation of phosphodiester linkages which are needed for the completion of nucleic acid chains. The compound is a potent inhibitor of HIV replication, acting as a chain-terminator of viral DNA during reverse transcription. It improves immunologic function, partially reverses the HIV-induced neurological dysfunction, and improves certain other clinical abnormalities associated with AIDS. Its principal toxic effect is dose-dependent suppression of bone marrow, resulting in anemia and leukopenia. AZT (Antiviral),Azidothymidine,3'-Azido-2',3'-Dideoxythymidine,3'-Azido-3'-deoxythymidine,AZT Antiviral,AZT, Antiviral,BW A509U,BWA-509U,Retrovir,3' Azido 2',3' Dideoxythymidine,3' Azido 3' deoxythymidine,Antiviral AZT,BWA 509U,BWA509U

Related Publications

E Aguilar Ligorit, and I Benet Monforte, and A Pascual López, and J García-Conde Bru
Zidovudine therapy and myopathies associated with human immunodeficiency virus infection.
February 1994, Annals of neurology,
E Aguilar Ligorit, and I Benet Monforte, and A Pascual López, and J García-Conde Bru
Early changes of neopterin concentrations during treatment of human immunodeficiency virus infection with zidovudine.
April 1992, The Journal of infectious diseases,
E Aguilar Ligorit, and I Benet Monforte, and A Pascual López, and J García-Conde Bru
Zidovudine treatment of an infant with congenital human immunodeficiency virus infection.
December 1990, The Pediatric infectious disease journal,
E Aguilar Ligorit, and I Benet Monforte, and A Pascual López, and J García-Conde Bru
[Nephropathie associated with human immunodeficiency virus infection: possible therapeutic value of zidovudine].
November 1991, Presse medicale (Paris, France : 1983),
E Aguilar Ligorit, and I Benet Monforte, and A Pascual López, and J García-Conde Bru
Human immunodeficiency virus associated with thrombotic thrombocytopenic purpura: successful treatment with zidovudine.
April 1991, Southern medical journal,
E Aguilar Ligorit, and I Benet Monforte, and A Pascual López, and J García-Conde Bru
Zidovudine and nephropathy with human immunodeficiency virus (HIV) infection.
November 1989, Annals of internal medicine,
E Aguilar Ligorit, and I Benet Monforte, and A Pascual López, and J García-Conde Bru
Treatment of human immunodeficiency virus-related thrombocytopenia with zidovudine.
November 1988, JAMA,
E Aguilar Ligorit, and I Benet Monforte, and A Pascual López, and J García-Conde Bru
Administration of zidovudine for treatment of infection due to human immunodeficiency virus.
January 1991, Reviews of infectious diseases,
E Aguilar Ligorit, and I Benet Monforte, and A Pascual López, and J García-Conde Bru
Zidovudine response relationships in early human immunodeficiency virus infection.
November 1993, Clinical pharmacology and therapeutics,
E Aguilar Ligorit, and I Benet Monforte, and A Pascual López, and J García-Conde Bru
Human immunodeficiency virus-associated autonomic neuropathy, drug addiction, and zidovudine treatment.
February 1993, Archives of internal medicine,
Copied contents to your clipboard!